The most up-to-date approach for treating morbid obesity is electronic implants tricking the brains into proffering a false sense of fullness. It has been touted to be a safer, lesser-invasive substitute to gastric bypass or even usual bariatric surgery for treatment of obese individuals who are diabetics & have other co-morbidities.
The new-fangled therapy functions by detection of foods on reaching the stomach & then conveying electric signalling to the brains that tummy fullness has been felt prior to it truly occurring.
Dubbed ‘The Abiliti system’, its basis being the same technology deployed in heart pacemaker devices. Implantation of the mini battery-run titanium pacemaker is done sub-dermally underneath the rib area & taking around one hour & generally an outpatient method. An electrode & victual identification sensor is affixed to the gadget that is implanted within the obese person’s abdominal area through keyhole surgical procedure.
Activation of the device is done after some time having passed by post-surgery, with every device set separately, on the basis of levels of stimulation needed for controlling appetites of patients.
No sooner has the sensor detected foods or beverages, it would be signalling to the tool which would then convey electric impulses to the abdominally-placed electrode that causes vagus nerve stimulation. It would be controlling digestive system movements & assimilation juices being produced. The vagus nerve would then be signalling to the appetite-controlling centre of the brain. Usually, the abdominal wall-located nerve receptors would be notifying the brain whenever fullness is sensed. However the Abiliti system would effectually be speeding up such messaging conveyed. It is also believed to slow down abdominal hormones which usually boost appetites. Patients characteristically would not be sensing any pains when the small currents are given to the stomach or when muscles encasing the trocar location are stimulated and least extent of side-effects have been experienced by entrants.
The gadget has been devised for obese people having body mass index (BMI) in the range of thirty-five to fifty-five or those with morbid obesity. No sooner have these people attained a healthful body mass index lying in the range of 18.5-24.9 then the tool could be turned off or taken out.
A. Sarela from the Nuffield Health Leeds Hosp. is the person pioneering this operative procedure which is being called as gastric pacing. This operative method for tackling morbid obesity is currently obtainable in Sheffield’s BMI Thornbury Hosp. as well as Nuffield and costing amid ten to fifteen thousand dollars & unavailable on the National Health Services.
Gastric pacing has been found to be risk-free & effectual for tackling morbid obesity in studies in Europe when it was conducted on 450 entrants globally. Study indicates that eighty percent of these people who opted for the surgery experienced weight loss subsequent to implanting the device, & sixty percent of the entrants shed ten percent of their weight over a span of twenty-nine months time they were followed up.